|
|
 |
|
Viewing report
|
|
|
|
The Pharmaceutical Market: Switzerland
Espicom Business Intelligence Ltd, Sep 2009, Pages: 84
EXECUTIVE SUMMARY 1
Introduction 2
Pharmaceutical Market Analysis 3
Size 3
Market Structure 3
Reimbursed Drug Market 5
Generics Sector 6
OKP Generic Market Data, 2006 6
Generic Outlook 7
OTC Sector 8
Projections & Outlook 10
Imports 13
Parallel Imports 14
Domestic Manufacturing 15
Domestic Production 15
Trade Association(s) 15
Interpharma 15
VIPS 16
Research-Based Manufacturers 17
Actelion 17
Boehringer-Ingelheim (Schweiz) GmbH 17
Cilag AG 17
Dr. Grossmann AG Pharmaca 17
Novartis 17
Roche 18
Siegfried CMS AG 18
Tillotts Pharma AG 18
Trichema AG 18
Vifor 19
Generic Manufacturers 19
Acino Pharma (formerly Cimex) 19
Helvepharm 19
Sandoz Pharmaceuticals 19
Spirig 20
Streuli Pharma 20
Exports 21
Research & Development 22
Pharmaceutical Regulatory Analysis 23
Pharmaceutical Regulation 23
Fast track Registration 24
Registered Drugs 24
Post-marketing Surveillance 25
Good Manufacturing Practice (GMP) Regulations 25
ADR Reports 26
Pricing & Reimbursement 26
Generic pricing 26
Intellectual Property 27
Pharmaceutical Distribution 28
Wholesaling 28
Amedis-UE AG 28
Galenica Holding 28
Voigt AG 28
Retailing 29
Healthcare Analysis 31
Demographics 31
Population 31
Birth Rate 31
Death Rate 31
Infant Mortality 32
Life Expectancy at Birth 32
Public Health 32
Causes of Death 32
Incidence of Communicable Diseases 32
HIV/AIDS 32
Healthcare System 33
Health Expenditure 34
Healthcare Infrastructure 35
Inpatient Analysis 36
Healthcare Personnel 37
DIRECTORY 38
Methodology & Sources 40
List of Tables
Summary of Key Data Projections, 2008-2013 2
Summary of the Swiss Pharmaceutical Market, 2008 3
Pharmaceutical Market Expenditure at Manufacturers Prices, 2002-07 (SFrmillions). 3
Pharmaceutical Product Pack Consumption by Distributing Source, 2002-07 (SFrmillions) 4
Average Price per Medicine Pack, 2002-07 (SFr) 5
Reimbursed Market Expenditure, 2002-07 (SFrmillion) 5
Generics Market (Manufacturers Prices), 2002-2007 6
Generics in the OKP Market, 2006 7
Generics in the OKP Market, 2006 (%) 7
Pro-Generic Measures, 2001-08 8
OTC Expenditure by Sales Channel, 2007 8
OTC Sales by Leading Therapeutic Area, 2005-07 (euro millions) 9
Key Market Projections, 2008-2013 10
SWOT Analysis of the Swiss Pharmaceutical Market 10
Espicom Analysis of Switzerland’s Health Sector 11
Imports of Pharmaceuticals by Category, 2002-2006 (US$000s) 13
Import Trends 13
Leading Suppliers of Raw Materials, 2006 (US$000s) 14
Leading Suppliers of Medicaments, 2006 (US$000s) 14
Interpharma Members, Sales, R&D and Workforce, 2007 (SFrmillions) 15
VIPS members, 2008 16
Exports of Pharmaceuticals, 2002-2006 (US$000s) 21
Export Trends 21
Leading Destinations, 2006 (US$000s) 21
Interpharma Members, R&D Expenditure in Switzerland, 2007 (SFrmillions) 22
Registered Human Preparations by Registration List, 2004-2007 23
New Registrations by Category, 1999-2007 24
Registered Drugs, 2000-07 24
ADR Reports by Source, 2002-07 26
Swiss Generic Price Level, EU comparison, 2006 (Index) 27
Pharmacies by Region and Canton, 2004-07 29
Drugstores, 1985-2007 30
Dispensing Doctors, 1985-2007 30
Summary of Demographic Data 31
Projected Population, 2008-2013 31
Summary Causes of Death, 2002-06 32
Healthcare Expenditure 34
Projected Health Expenditure, 2008-2013 34
Hospitals & Beds 35
Hospital Bed Projections, 2008-2013 35
Inpatient Admissions by ICD Classification, 2006 36
Projected Number of Physicians, 2008-2013 37
Customers who bought this item also bought
The Pharmaceutical Market: Mexico
The Pharmaceutical Market: Portugal
The Pharmaceutical Market: Netherlands
The Pharmaceutical Market: Colombia
The Medical Device Market: Switzerland
Understanding the Global Pharmaceutical Market
The Pharmaceutical Market: Thailand
The Pharmaceutical Market: Ireland
The Pharmaceutical Market: Poland
The Pharmaceutical Market: Romania
The Pharmaceutical Market: Bulgaria
The Pharmaceutical Market: UK
|
|
|
|
